🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Tesla, ABB And Other Big Losers From Monday

Published 04/10/2022, 10:00
Updated 04/10/2022, 10:40
© Reuters Tesla, ABB And Other Big Losers From Monday
ABBN
-
TSLA
-
IXIC
-
ABBNY
-

U.S. stocks closed sharply higher with the Dow Jones jumping more than 750 points on Monday. Here is the list of some big stocks recording losses in the previous session.

  • Aura Biosciences, Inc. (NASDAQ: AURA) fell 19.5% to close at $14.59. Aura Biosciences announced interim Phase 2 data evaluating suprachoroidal administration of belzupacap sarotalocan for the first-line treatment of patients with early-stage choroidal melanoma presented at the AAO 2022.
  • GigaCloud Technology Inc. (NASDAQ: GCT) dropped 18.5% to close at $8.24. Aegis Capital initiated coverage on GigaCloud Tech with a Buy rating and announced a price target of $26.
  • Belite Bio, Inc (NASDAQ: BLTE) fell 14% to close at $29.10. Belite Bio presented 12-month interim results of LBS-008 Phase 1b/2 study in adolescent Stargardt disease at the AAO Annual Meeting 2022.
  • Hippo Holdings Inc. (NYSE: HIPO) fell 12.8% to close at $16.16.
  • Third Harmonic Bio, Inc. (NASDAQ: THRD) dropped 10.4% to close at $17.00.
  • AMC Entertainment Holdings, Inc. (NYSE: APE) fell 10% to close at $2.44.
  • Lilium N.V. (NASDAQ: LILM) dropped 9.2% to close at $2.07. Lilium recently announced partnership with GlobeAir.
  • Tesla, Inc. (NASDAQ: TSLA (NASDAQ:TSLA)) shares fell 8.6% to close at $242.40 after the company reported third-quarter vehicle deliveries below Wall Street expectations. Tesla said it produced 365,923 vehicles in the quarter and delivered 343,830.
  • EQRx, Inc. (NASDAQ: EQRX) dropped 7.5% to close at $4.58.
  • H&R Block, Inc. (NYSE: HRB) fell 5.3% to settle at $40.29.
  • ABB Ltd (NYSE: ABB) dropped 5.3% to close at $24.30 after the company completed the spin off of its turbocharging business.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.